Driving innovation in pharma to accelerate drug development

For a healthier future

The pharmaceutical sector faces rising R&D costs, stricter regulation and pressure to deliver effective therapies faster. TNO supports the industry with advanced science, predictive models and data-driven methods that reduce development risks and accelerate decision making. With innovative biomarkers, AI-enabled discovery and next-generation preclinical systems, we help the pharmaceutical industry to turn their promising concepts faster into strong therapeutic candidates.

As diseases become more complex and global health and personalised medicine continue to evolve, TNO brings together integrated biological, computational and engineering expertise to break through R&D bottlenecks and enhance clinical success rates. Our facilities and collaborative approach offer a reliable foundation for faster and more sustainable drug development.

Discover how TNO can strengthen your pipeline and accelerate the path from scientific insight to real world therapies.

Research

Where TNO adds value

Need scientific validation or deeper insight? TNO supports your pharma challenges with independent, evidence based research.

Research

Need scientific validation or deeper insight? TNO supports your pharma challenges with independent, evidence based research.

Innovation

Where TNO adds value

Developing a new product or technology without the right facilities or expertise? TNO accelerates and strengthens your development process.

Innovation

Developing a new product or technology without the right facilities or expertise? TNO accelerates and strengthens your development process.

Collaborate

Where TNO adds value

Exploring partnership opportunities? TNO offers collaborative programmes and expert guidance to advance your R&D.

Collaborate

Exploring partnership opportunities? TNO offers collaborative programmes and expert guidance to advance your R&D.

‘At TNO, we believe that patients deserve faster access to life-changing treatments. By applying advanced technologies such as microtracing and AMS, we enable pharmaceutical partners to spot risks earlier, cut unnecessary delays, and shorten development times. With smarter models, better predictions, and collaborative innovation, we bring effective medicines to people sooner—helping build a more resilient, healthier future.’

Martin Kirch

Market Director Health, TNO

Would you like to know how TNO can contribute to accelerating your (preclinical) drug development process?

TNO offers well validated unique models and technologies that help pharma in decision making and development of their (preclinical) pipeline. In creating innovations we collaborate with around 3,000 large multinationals, SMEs, universities, knowledge institutions and governments, at home and abroad on joint challenges.

This is how we do it

Get inspired

22 resultaten, getoond 1 t/m 5

Obesity

Informatietype:: Article

Advance obesity drug development with TNO’s translational Ldlr−/−.Leiden mouse model. Generate clinically relevant, multi-organ efficacy data with AI-supported analysis that closely aligns with human outcomes.

over Obesity